Is rapid preparation for thyroidectomy in severe Graves' disease beneficial? The relationship between clinical and immunohistochemical aspects

Endocrine

Volumn 33, Issue 2, 2008, Pages 189-195

  Hassan, Iyad ^a   Danila, Radu ^a   Aljabri, Heisam ^a   Hoffmann, Sebastian ^a   Wunderlich, Annette ^a   Karakas, Elias ^a   Zielke, Andreas ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Angiogenesis; Graves' disease; Immunochemistry; Lugol's Iodine; Morbidity; VEGF

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CD31 ANTIGEN; LUGOL; THIONAMIDE; VASCULOTROPIN; IODIDE; LUGOL'S SOLUTION; VASCULOTROPIN A;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BLEEDING; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GRAVES DISEASE; HUMAN; HUMAN TISSUE; HYPOCALCEMIA; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MICROVASCULATURE; MORBIDITY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENT LARYNGEAL NERVE PALSY; TACHYCARDIA; THYROIDECTOMY; VASCULARIZATION; ADOLESCENT; BIOSYNTHESIS; BLOOD FLOW; CHILD; METABOLISM; MIDDLE AGED; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PHYSIOLOGY; THYROID GLAND;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD31; CHILD; FEMALE; GRAVES DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; IODIDES; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; POSTOPERATIVE COMPLICATIONS; REGIONAL BLOOD FLOW; THYROID GLAND; THYROIDECTOMY; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 49649085565     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-008-9076-8     Document Type: Article

References (31)

1. H. Dralle C. Sekulla 2004 Morbidity after subtotal and total thyroidectomy in patients with Graves' disease: the basis for decision-making regarding surgical indication and extent of resection Z Arztl Fortbild Qualitatssich 98 Suppl 5 45 53
2. B. Winsa J. Rastad G. Akerstrom H. Johansson K. Westermark F.A. Karlsson 1995 Retrospective evaluation of subtotal and total thyroidectomy in Graves' disease with and without endocrine ophthalmopathy Eur J Endocrinol 132 4 406 412
3. I. Hassan M. Koller C. Kluge S. Hoffmann A. Zielke M. Rothmund 2006 Supervised surgical trainees perform thyroid surgery for Graves' disease safely Langenbecks Arch Surg 391 597 602
4. P. Abraham A. Avenell C.M. Park W.A. Watson J.S. Bevan 2005 A systematic review of drug therapy for Graves' hyperthyroidism Eur J Endocrinol 153 489
5. S. Nagura R. Katoh E. Miyagi M. Shibuya A. Kawaoi 2001 Expression of vascular endothelial growth factor (VEGF), VEGF receptor-1 (Flt-1) in Graves disease possibly correlated with increased vascular density Hum Pathol 32 1 10 17
6. T. Nagasaki M. Inaba Y. Kumeda M. Fujiwara-Ueda Y. Hiura Y. Nishizawa 2007 Significance of thyroid blood flow as a predictor of methimazole sensitivity in untreated hyperthyroid patients with Graves' disease Biomed Pharmacother 61 8 472 476
7. E.N. Pearce 2006 Diagnosis and management of thyrotoxicosis BMJ 332 1369 1373
8. D.E. Henley J.M. Kaye H.H. Nguyen J.P. Walsh 2006 Rapid preparation of patients with Graves' hyperthyroidism for urgent thyroidectomy Intern Med J 36 1 63 64
9. J.F. Rodier J.C. Janser H. Petit O. Schneegans G. Ott A. Kaissling J.C. Grob 1998 Effect of preoperative administration of Lugol solution on thyroid blood flow in hyperthyroidism Ann Chir 52 229 233
10. D.C. Chang M.H. Wheeler J.P. Woodcock I. Curley J.R. Lazarus H. Fung R. John R. Hall A.M. McGregor 1987 The effect of preoperative Lugol iodine on thyroid blood flow in patients with Graves' hyperthyroidism Surgery 102 1055 1061
11. S. Kaur J.H. Parr I.D. Ramsay T.M. Hennebry K.J. Jarvis E. Lester 1988 Effect of preoperative iodine in patients with Graves' disease controlled with antithyroid drugs and thyroxine. Lester E Ann R Coll Surg Engl 70 123 127
12. W. Risau 1997 Mechanisms of angiogenesis Nature 386 671 674
13. M. Toi K. Inada H. Suzuki T. Tominaga 1995 Tumor angiogenesis in breast cancer: its association with vascular endothelial growth factor expression Breast Cancer Res Treat 36 193 204
14. G.L. Ansaldo F. Pretolesi E. Varaldo C. Meola M. Minuto G. Borgonovo L.E. Derchi G.C. Torre 2000 Doppler evaluation of intrathyroid arterial resistances during preoperative treatment with Lugol iodide solution in patients with diffuse toxic goiter J Am Coll Surg 191 607 612
15. N. Ferrara K. Houck L. Jakeman D.W. Leung 1992 Molecular and biological properties of the vascular endothelial growth factor family of proteins Endocr Rev 13 18 32
16. C. Fenton A. Patel C. Dinauer D.K. Robie R.M. Tuttle G.L. Francis 2000 The expression of vascular endothelial growth factor and the type 1 vascular endothelial growth factor receptor correlate with the size of papillary thyroid carcinoma in children and young adults Thyroid 10 349 357
17. J.D. Ramsden 2000 Angiogenesis in the thyroid gland J Endocrinol 166 475 480
18. Y. Nakamura H. Yasuoka H. Zuo Y. Takamura A. Miyauchi M. Nakamura K. Kakudo 2006 Nitric oxide in papillary thyroid carcinoma: induction of vascular endothelial growth factor D and correlation with lymph node metastasis Clin Endocrinol Metab 91 4 1582 1585
19. K. Sato M. Miyakawa N. Onoda H. Demura T. Yamashita M. Miura T. Kasajima K. Yamazaki T. Obara 1997 Increased concentration of vascular endothelial growth factor/vascular permeability factor in cyst fluid of enlarging and recurrent thyroid nodules J Clin Endocrinol Metab 82 1968 1973
20. S.H. Wollman J.P. Herveg J.D. Zeligs L.E. Ericson 1978 Blood capillary enlargement during the development of thyroid hyperplasia in the rat Endocrinology 103 2306 2314
21. A. Jebreel J. England K. Bedford J. Murphy L. Karsai S. Atkin 2007 Vascular endothelial growth factor (VEGF), VEGF receptors expression and microvascular density in benign and malignant thyroid diseases Int J Exp Pathol 88 4 271 277
22. M. Iitaka S. Miura K. Yamanaka S. Kawasaki S. Kitahama Y. Kawakami S. Kakinuma I. Oosuga S. Wada S. Katayama 1998 Increased serum vascular endothelial growth factor levels and intrathyroidal vascular area in patients with Graves' disease and Hashimoto's thyroiditis J Clin Endocrinol Metab 83 11 3908 3912
23. P.J. Barth K. Weingärtner H.H. Köhler A. Bittinger 1996 Assessment of the vascularization in prostatic carcinoma: a morphometric investigation Hum Pathol 27 12 1306 1310
24. A.P. Weetman 1995 Graves' disease N Engl J Med 343 1236 1248
25. D.S. Cooper 2003 Hyperthyroidism Lancet 362 459 468
26. H.S. Plummer 1923 Results of administering iodine to patients having exophtalmic goiter JAMA 80 1955
27. Clapesattle H. The Doctors Mayo (Mayo Foundation for Medical Education and Research, Rochester, 1990), 220-221, 232-236, 298-299, 306-327, 369-372
28. E. Yamada K. Yamazaki K. Takano T. Obara K. Sato 2006 Iodide inhibits vascular endothelial growth factor-A expression in cultured human thyroid follicles: a microarray search for effects of thyrotropin and iodide on angiogenesis factors Thyroid 16 6 545 554
29. G. Bunone P. Vigneri L. Mariani S. Butó P. Collini S. Pilotti M.A. Pierotti I. Bongarzone 1999 Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features Am J Pathol 155 6 1967 1976
30. M. Rangaswamy A.K. Padhy P.G. Gopinath N.K. Shukla K. Gupta M.M. Kapoor 1989 Effect of Lugol's iodine on the vascularity of thyroid gland in hyperthyroidism Nucl Med Commun 10 9 679 684
31. Y. Erbil Y. Ozluk M. Giriş A. Salmaslioglu H. Issever U. Barbaros Y. Kapran S. Ozarmaǧan S. Tezelman 2007 Effect of lugol solution on thyroid gland blood flow and microvessel density in the patients with Graves' disease J Clin Endocrinol Metab 2 6 2182 2189